http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5690931-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ee5285e8e8edccb061046ff20da7a6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49
filingDate 1994-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_098071d0b05bb753ca5c4fb1d28b0f8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17e0c7d900c8e72f39b4c04c9204477
publicationDate 1997-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5690931-A
titleOfInvention Method for treating thromboembolic conditions via the use of multiple bolus administration of thrombolytically active proteins
abstract Discussed are therapeutic approaches to the treatment of thrombolic conditions. The therapies use thrombolytically active proteins which function by, e.g., inhibiting reocclusion in the subject. The proteins are administered in two or more boli.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004029798-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009004177-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003152956-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011015188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010196348-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006205662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7084118-B2
priorityDate 1991-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5223256-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9008557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0211592-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5342616-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8900197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0352119-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4935237-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4970159-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0196920-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4980165-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0352897-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 44.